{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T22:57:59Z","timestamp":1789340279694,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,20]]},"DOI":"10.7759\/cureus.67284","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T10:15:51Z","timestamp":1724148951000},"source":"Crossref","is-referenced-by-count":3,"title":["Navigating Primary Immune Thrombocytopenia During Pregnancy: Management Strategies and Considerations: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Bhavana V","family":"Waghmare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhada","family":"Jajoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Betterhealth. Idiopathic thrombocytopenic purpura (ITP). (2023). Accessed: April 4, 2024: http:\/\/www.betterhealth.vic.gov.au\/health\/conditionsandtreatments\/idiopathic-thrombocytopenic-purpura-itp."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000574","article-title":"Immune thrombocytopenia: recent advances in pathogenesis and treatments","volume":"5","author":"Audia S","year":"2021","unstructured":"Audia S, Mah\u00e9vas M, Nivet M, Ouandji S, Ciudad M, Bonnotte B. Immune thrombocytopenia: recent advances in pathogenesis and treatments. Hemasphere. 2021, 5:e574. 10.1097\/HS9.0000000000000574","journal-title":"Hemasphere"},{"key":"ref3","article-title":"Immune thrombocytopenic purpura","author":"Pietras NM","year":"2024","unstructured":"Pietras NM, Pearson-Shaver AL. Immune thrombocytopenic purpura. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.08.005","article-title":"Immune thrombocytopenia in pregnancy","volume":"23","author":"Stavrou E","year":"2009","unstructured":"Stavrou E, McCrae KR. Immune thrombocytopenia in pregnancy. Hematol Oncol Clin North Am. 2009, 23:1299-316. 10.1016\/j.hoc.2009.08.005","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref5","article-title":"Thrombocytopenia in pregnancy","author":"Mangla A","year":"2024","unstructured":"Mangla A, Hamad H. Thrombocytopenia in pregnancy. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref6","article-title":"Thrombocytopenia in pregnancy","volume":"11","author":"Ciobanu AM","year":"2016","unstructured":"Ciobanu AM, Colibaba S, Cimpoca B, Peltecu G, Panaitescu AM. Thrombocytopenia in pregnancy. Maedica (Bucur). 2016, 11:55-60.","journal-title":"Maedica (Bucur)"},{"key":"ref7","article-title":"ITP-Immune thrombocytopenic purpura","author":"Justiz Vaillant AA","year":"2024","unstructured":"Justiz Vaillant AA, Gupta N. ITP-Immune thrombocytopenic purpura. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040789","article-title":"Primary immune thrombocytopenia: novel insights into pathophysiology and disease management","volume":"10","author":"Singh A","year":"2021","unstructured":"Singh A, Uzun G, Bakchoul T. Primary immune thrombocytopenia: novel insights into pathophysiology and disease management. J Clin Med. 2021, 10:10.3390\/jcm10040789","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia S","year":"2017","unstructured":"Audia S, Mah\u00e9vas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017, 16:620-32. 10.1016\/j.autrev.2017.04.012","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5045\/br.2022.2022068","article-title":"Diagnosis and management of thrombocytopenia in pregnancy","volume":"57","author":"Park YH","year":"2022","unstructured":"Park YH. Diagnosis and management of thrombocytopenia in pregnancy. Blood Res. 2022, 57:79-85. 10.5045\/br.2022.2022068","journal-title":"Blood Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/aob-21-73","article-title":"Pregnancy and postpartum transfusion","volume":"7","author":"Linder GE","year":"2022","unstructured":"Linder GE, Ipe TS. Pregnancy and postpartum transfusion. Annals of Blood. 2022, 7:1-8. 10.21037\/aob-21-73","journal-title":"Annals of Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5045\/br.2014.49.4.259","article-title":"Can we predict neonatal thrombocytopenia in offspring of women with idiopathic thrombocytopenic purpura?","volume":"49","author":"Hachisuga K","year":"2014","unstructured":"Hachisuga K, Hidaka N, Fujita Y, Fukushima K, Kato K. Can we predict neonatal thrombocytopenia in offspring of women with idiopathic thrombocytopenic purpura?. Blood Res. 2014, 49:259-64. 10.5045\/br.2014.49.4.259","journal-title":"Blood Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3928\/00904481-20150710-11","article-title":"Neonatal thrombocytopenia: etiology and diagnosis","volume":"44","author":"Sillers L","year":"2015","unstructured":"Sillers L, Van Slambrouck C, Lapping-Carr G. Neonatal thrombocytopenia: etiology and diagnosis. Pediatr Ann. 2015, 44:e175-80. 10.3928\/00904481-20150710-11","journal-title":"Pediatr Ann"},{"key":"ref14","unstructured":"Immune Thrombocytopenia and Pregnancy. Practice essentials, pathophysiology, epidemiology. (2023). Accessed: April 26, 2024: https:\/\/emedicine.medscape.com\/article\/208697-overview."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019, 3:3829-66. 10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000001144","article-title":"Primary immune thrombocytopenia: a 'diagnosis of exclusion'?","volume":"33","author":"Visweshwar N","year":"2022","unstructured":"Visweshwar N, Ayala I, Jaglal M, Killeen R, Sokol L, Laber DA, Manoharan A. Primary immune thrombocytopenia: a 'diagnosis of exclusion'?. Blood Coagul Fibrinolysis. 2022, 33:289-94. 10.1097\/MBC.0000000000001144","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-448944","article-title":"How I treat thrombocytopenia in pregnancy","volume":"121","author":"Gernsheimer T","year":"2013","unstructured":"Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood. 2013, 121:38-47. 10.1182\/blood-2012-08-448944","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/20406207221095226","article-title":"Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study","volume":"13","author":"Zhu XL","year":"2022","unstructured":"Zhu XL, Feng R, Huang QS, et al.. Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study. Ther Adv Hematol. 2022, 13:20406207221095226. 10.1177\/20406207221095226","journal-title":"Ther Adv Hematol"},{"key":"ref19","article-title":"Safety and efficacy of azathioprine in immune thrombocytopenia","volume":"11","author":"Mishra K","year":"2021","unstructured":"Mishra K, Pramanik S, Sandal R, et al.. Safety and efficacy of azathioprine in immune thrombocytopenia. Am J Blood Res. 2021, 11:217-26.","journal-title":"Am J Blood Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2021.05.004","article-title":"Use of thrombopoietin receptor agonists in pregnancy: A review of the literature","volume":"15","author":"Howaidi J","year":"2022","unstructured":"Howaidi J, AlRajhi AM, Howaidi A, AlNajjar FH, Tailor IK. Use of thrombopoietin receptor agonists in pregnancy: A review of the literature. Hematol Oncol Stem Cell Ther. 2022, 15:1-6. 10.1016\/j.hemonc.2021.05.004","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2013.01.014","article-title":"The management of hypertension in pregnancy","volume":"20","author":"Kattah AG","year":"2013","unstructured":"Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013, 20:229-39. 10.1053\/j.ackd.2013.01.014","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-020-01390-w","article-title":"Maternal and fetal outcomes of pregnancy in patients with immune thrombocytopenia","volume":"71","author":"Kashyap R","year":"2021","unstructured":"Kashyap R, Garg A, Pradhan M. Maternal and fetal outcomes of pregnancy in patients with immune thrombocytopenia. J Obstet Gynaecol India. 2021, 71:124-30. 10.1007\/s13224-020-01390-w","journal-title":"J Obstet Gynaecol India"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-019-01420-w","article-title":"Obstetric neuraxial anesthesia at low platelet counts in the context of immune thrombocytopenia: a systematic review and meta-analysis","volume":"66","author":"Bailey LJ","year":"2019","unstructured":"Bailey LJ, Shehata N, De France B, Carvalho JC, Malinowski AK. Obstetric neuraxial anesthesia at low platelet counts in the context of immune thrombocytopenia: a systematic review and meta-analysis. Can J Anaesth. 2019, 66:1396-414. 10.1007\/s12630-019-01420-w","journal-title":"Can J Anaesth"},{"key":"ref24","article-title":"Acute postpartum hemorrhage","author":"Wormer KC","year":"2024","unstructured":"Wormer KC, Jamil RT, Bryant SB. Acute postpartum hemorrhage. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6633790","article-title":"Marked rebound of platelet count in the early postpartum period in a patient with essential thrombocythemia","volume":"2021","author":"Hashimoto Y","year":"2021","unstructured":"Hashimoto Y, Hosoda R, Omura H, Tanaka T. Marked rebound of platelet count in the early postpartum period in a patient with essential thrombocythemia. Case Rep Hematol. 2021, 2021:6633790. 10.1155\/2021\/6633790","journal-title":"Case Rep Hematol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038587","article-title":"Is it possible to predict morbidities in neonates born to mothers with immune thrombocytopenic purpura?: A retrospective cross-sectional study","volume":"103","author":"Aslan MT","year":"2024","unstructured":"Aslan MT, \u0130nce Z, Bilgin L, Kunt \u0130\u015fg\u00fcder \u00c7, \u00c7oban A. Is it possible to predict morbidities in neonates born to mothers with immune thrombocytopenic purpura?: A retrospective cross-sectional study. Medicine (Baltimore). 2024, 103:e38587. 10.1097\/MD.0000000000038587","journal-title":"Medicine (Baltimore)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000758","article-title":"Neonates born to mothers with immune thrombocytopenia: 11 years experience of a single academic center","volume":"29","author":"Karakurt N","year":"2018","unstructured":"Karakurt N, Uslu \u0130, Albayrak C, Tomak L, Ozyazici E, Albayrak D, Aygun C. Neonates born to mothers with immune thrombocytopenia: 11 years experience of a single academic center. Blood Coagul Fibrinolysis. 2018, 29:546-50. 10.1097\/MBC.0000000000000758","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000378","article-title":"Neonates born to mothers with immune thrombocytopenic purpura: a single-center experience of 20 years","volume":"27","author":"Bayhan T","year":"2016","unstructured":"Bayhan T, Tavil B, Korkmaz A, et al.. Neonates born to mothers with immune thrombocytopenic purpura: a single-center experience of 20 years. Blood Coagul Fibrinolysis. 2016, 27:19-23. 10.1097\/MBC.0000000000000378","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01401-z","article-title":"How we treat primary immune thrombocytopenia in adults","volume":"16","author":"Liu XG","year":"2023","unstructured":"Liu XG, Hou Y, Hou M. How we treat primary immune thrombocytopenia in adults. J Hematol Oncol. 2023, 16:4. 10.1186\/s13045-023-01401-z","journal-title":"J Hematol Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1055\/a-1837-7581","article-title":"Bleeding complications associated with pregnancy with primary immune thrombocytopenia: a meta-analysis","volume":"6","author":"Gonzalez-Porras JR","year":"2022","unstructured":"Gonzalez-Porras JR, Palomino D, Vaquero-Roncero LM, Bastida JM. Bleeding complications associated with pregnancy with primary immune thrombocytopenia: a meta-analysis. TH Open. 2022, 6:e230-7. 10.1055\/a-1837-7581","journal-title":"TH Open"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2021.00248","article-title":"Worldwide national intervention of developmental screening programs in infant and early childhood","volume":"65","author":"Kim S","year":"2022","unstructured":"Kim S. Worldwide national intervention of developmental screening programs in infant and early childhood. Clin Exp Pediatr. 2022, 65:10-20. 10.3345\/cep.2021.00248","journal-title":"Clin Exp Pediatr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1258\/om.2011.110025","article-title":"Immune thrombocytopenia and pregnancy","volume":"4","author":"Sankaran S","year":"2011","unstructured":"Sankaran S, Robinson SE. Immune thrombocytopenia and pregnancy. Obstet Med. 2011, 4:140-6. 10.1258\/om.2011.110025","journal-title":"Obstet Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-201778","article-title":"Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura","volume":"2013","author":"Mahey R","year":"2013","unstructured":"Mahey R, Kaur SD, Chumber S, Kriplani A, Bhatla N. Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura. BMJ Case Rep. 2013, 2013:10.1136\/bcr-2013-201778","journal-title":"BMJ Case Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12206422","article-title":"Recommendations for the clinical approach to immune thrombocytopenia: Spanish ITP working group (GEPTI)","volume":"12","author":"Mingot-Castellano ME","year":"2023","unstructured":"Mingot-Castellano ME, Canaro Hirnyk M, S\u00e1nchez-Gonz\u00e1lez B, et al.. Recommendations for the clinical approach to immune thrombocytopenia: Spanish ITP working group (GEPTI). J Clin Med. 2023, 12:10.3390\/jcm12206422","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5339\/qmj.2022.22","article-title":"Efficacy and safety of rituximab as second-line therapy in immune thrombocytopenic purpura based on ethnicity: A descriptive study among the Arabic population","volume":"2022","author":"Ata F","year":"2022","unstructured":"Ata F, Yousaf Z, Zahir FZ, et al.. Efficacy and safety of rituximab as second-line therapy in immune thrombocytopenic purpura based on ethnicity: A descriptive study among the Arabic population. Qatar Med J. 2022, 2022:22. 10.5339\/qmj.2022.22","journal-title":"Qatar Med J"},{"key":"ref36","article-title":"Severe gestational thrombocytopenia: a case report and brief review of the literature","volume":"5","author":"Ramadan MK","year":"2017","unstructured":"Ramadan MK, Hubeich M, Itani SE, Mogharbil A. Severe gestational thrombocytopenia: a case report and brief review of the literature. J Hematol. 2017, 5:142-50.","journal-title":"J Hematol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.799826","article-title":"Diagnostic ideas and management strategies for thrombocytopenia of unknown causes in pregnancy","volume":"9","author":"Li J","year":"2022","unstructured":"Li J, Gao YH, Su J, Zhang L, Sun Y, Li ZY. Diagnostic ideas and management strategies for thrombocytopenia of unknown causes in pregnancy. Front Surg. 2022, 9:799826. 10.3389\/fsurg.2022.799826","journal-title":"Front Surg"},{"key":"ref38","article-title":"Physiology, postpartum changes","author":"Chauhan G","year":"2024","unstructured":"Chauhan G, Tadi P. Physiology, postpartum changes. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.21037\/aob-20-58","article-title":"Management of immune thrombocytopenia in pregnancy","volume":"6","author":"Poston JN","year":"2021","unstructured":"Poston JN, Gernsheimer TB. Management of immune thrombocytopenia in pregnancy. Annals of Blood. 2021, 6:3389. 10.21037\/aob-20-58","journal-title":"Annals of Blood"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006732.pub4","article-title":"Interventions for increasing the use of shared decision making by healthcare professionals","volume":"7","author":"L\u00e9gar\u00e9 F","year":"2018","unstructured":"L\u00e9gar\u00e9 F, Adekpedjou R, Stacey D, et al.. Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2018, 7:CD006732. 10.1002\/14651858.CD006732.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-6-13","article-title":"Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective","volume":"6","author":"Mathias SD","year":"2008","unstructured":"Mathias SD, Gao SK, Miller KL, et al.. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008, 6:13. 10.1186\/1477-7525-6-13","journal-title":"Health Qual Life Outcomes"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-06089-0","article-title":"Women's experiences of social support during pregnancy: a qualitative systematic review","volume":"23","author":"Al-Mutawtah M","year":"2023","unstructured":"Al-Mutawtah M, Campbell E, Kubis HP, Erjavec M. Women's experiences of social support during pregnancy: a qualitative systematic review. BMC Pregnancy Childbirth. 2023, 23:782. 10.1186\/s12884-023-06089-0","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/285662-navigating-primary-immune-thrombocytopenia-during-pregnancy-management-strategies-and-considerations-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T10:15:55Z","timestamp":1724148955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/285662-navigating-primary-immune-thrombocytopenia-during-pregnancy-management-strategies-and-considerations-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.67284","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,20]]}}}